Are the LOXL1 gene variations associated with primary open-angle and primary angle-closure glaucomas?
The results from the present study do not indicate the involvement of the LOXL1 SNPs in POAG and PACG.
Diclocor is a promising corrector of inflammatory and destructive joint diseases. Owing to the presence of both diclofenac sodium and quercetin in its composition, Diclocor exhibits a complex mechanism of anti-inflammatory action affecting cyclooxygenase and lipoxygenase ways of arachidonic acid biotransformation.